Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Eleusinia Retreat Marks 1,500 Participants and 115 Retreats, Bringing Rigorous Psychedelic Care to Those the Industry Left Behind


News provided by

Eleusinia Retreat

Jun 21, 2026, 16:00 ET

Share this article

Share toX

Share this article

Share toX


Founded by a Patient Who Built What She Couldn't Find, Eleusinia Has Become One of the Most Experienced Psilocybin Retreat Programs in the World

VALLE DE BRAVO, Mexico, June 21, 2026 /PRNewswire-PRWeb/ -- Eleusinia Retreat, a medically supervised psilocybin and DMT retreat program based in Valle de Bravo, Mexico, today announced a milestone of more than 1,500 participants supported across 115 retreats and approximately 4,800 individual psilocybin experiences since the program's founding in 2021. The announcement reflects the growing demand for psychedelic care that meets participants with clinical seriousness, scientific grounding, and genuine therapeutic depth.

Eleusinia was founded by Jessica Khurana, who came to the retreat space not as a wellness entrepreneur but as a patient. In 2019, Khurana was diagnosed with hemicrania continua, a rare and debilitating chronic headache condition that conventional medicine failed to adequately treat. By 2020, her quality of life had deteriorated to the point where she began researching psilocybin through the Clusterbusters patient community, a network focused on psychedelic treatment for cluster headache disorders. Finding no retreat that could engage with her condition at a medical level, she administered the protocol independently. It took five sessions before she was pain free.

We are here for the people who are done being told their suffering is untreatable, who want to engage with this medicine thoughtfully and come out the other side with real tools.

Post this

When Khurana explored retreat options during that period, she encountered a field that was long on mysticism and short on medical credibility. One operator, on a discovery call, suggested that mushrooms would help her vomit up the bad energy causing her headaches. That moment clarified the problem: the patients who needed this medicine most had nowhere to go that could meet them as equals.

"I am just so moved to see how people are taking this knowledge and using it to improve their lives," said Khurana. "That is exactly why Eleusinia exists. We built the infrastructure so that people do not have to navigate this alone the way I did."

She founded Eleusinia in 2021 with a single guiding philosophy: to build the retreat she wished had existed. The result is a program that combines licensed medical oversight, psychotherapy, neuroscience education, ancestral wisdom, and somatic integration within a small-group, exclusively private format in the mountains of central Mexico.

Eleusinia's on-site care team reflects its founding commitment to clinical rigor. The program is staffed by a licensed medical doctor, a CCRN-certified critical care nurse with more than 20 years of intensive care experience, an emergency medicine physician assistant, and a licensed psychotherapist certified in psychedelic-assisted psychotherapy through Naropa University's MAPS program. A traditional curandera representing Mixtec, Zapotec, and Mayan lineages has been present at every ceremony since the retreat's first session. A staff mycologist oversees the cultivation and quality of all psilocybin on-site.

Khurana delivers the neuroscience and psychopharmacology curriculum at every retreat personally, and leads morning fitness training alongside facilitation of every dosing session. The program is designed to send guests home with skills and independence rather than dependence on a facilitator or program.

The 1,500 participants Eleusinia has served represent a cross-section of people who found in psychedelic care what conventional medicine could not provide: relief from treatment-resistant depression, chronic pain, anxiety, addiction, and a search for meaning and transformation that clinical systems rarely address. Eleusinia's 70-episode podcast, hosted by the retreat's medical coordinator and featuring interviews with past guests, offers firsthand accounts of the outcomes participants have experienced.

The retreat's flagship 8-Day Intensive Program runs in a small-group format of up to 14 participants, with exclusively private accommodations, in Valle de Bravo, a UNESCO-recognized Pueblo Magico set on a mountain lake approximately two hours from Mexico City.

"We are not here to be everything to everyone," said Khurana. "We are here for the people who are done being told their suffering is untreatable, who want to engage with this medicine thoughtfully and come out the other side with real tools. Five years in, watching 1,500 people do exactly that, I know we built the right thing."

To learn more about Eleusinia Retreat, visit www.eleusiniaretreat.com or watch the program overview video at https://youtu.be/pFsrvZ4dXew.

About Eleusinia Retreat

Eleusinia Retreat is a medically supervised psilocybin and DMT retreat program based in Valle de Bravo, Mexico, founded in 2021 by Jessica Khurana. The program offers 5-day, 7-day, and 8-day retreat formats including specialty programs in healthy aging, pain management, sobriety maintenance, and psychedelic-enhanced meditation. Eleusinia's multidisciplinary care team includes licensed medical doctors, critical care nurses, a physician assistant, a licensed psychotherapist with psychedelic-assisted therapy certification, a traditional curandera, somatic integration specialists, a staff mycologist, and meditation and breathwork facilitators. The retreat operates on a philosophy of autonomy, sending guests home with skills and independence rather than dependence on a program or facilitator. Since its founding, Eleusinia has supported more than 1,500 participants across 115 retreats and approximately 4,800 individual psilocybin experiences. Learn more at www.eleusiniaretreat.com.

Media Contact

Jessica Khurana, Eleusinia Retreat, 1 9852372434, [email protected], [email protected], (281) 206-4227, www.eleusiniaretreat.com

SOURCE Eleusinia Retreat

Modal title

Eleusinia Retreat Team
Eleusinia Retreat Team
Eleusinia Retreat Team

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.